Inventor · disambiguated record
Jay A. Markwalder
Also filed as: MARKWALDER JAY A · MARKWALDER JAY ANDREW
25 granted patents·1 pending application·274 citations·filing 1991–2020
95Inventor score
Files withBRISTOL MYERS SQUIBB CO13FLEXUS BIOSCIENCES INC5DU PONT PHARM CO3INNATE TUMOR IMMUNITY INC2DU PONT1
Top patents by PatentIndex Score
26 records- 0196US9643972B2Immunoregulatory agentsFLEXUS BIOSCIENCES INC·Filed 2015·Granted May 9, 2017·15 cites·47 claims
- 0296US9598422B2Immunoregulatory agentsFLEXUS BIOSCIENCES INC·Filed 2015·Granted Mar 21, 2017·21 cites·34 claims
- 0394US9790169B2IDO inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Oct 17, 2017·19 cites·27 claims
- 0494US5874430A4,4-disubstitued-1,4-dihydro-2H-3,1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and intermediates and processes for making the sameDU PONT PHARM CO·Filed 1997·Granted Feb 23, 1999·87 cites·22 claims
- 0593US10106546B2Immunoregulatory agentsFLEXUS BIOSCIENCES INC·Filed 2017·Granted Oct 23, 2018·6 cites·66 claims
- 0692US5260325AAngiotensin II receptor blocking tertiary amidesDU PONT·Filed 1991·Granted Nov 9, 1993·61 cites·6 claims
- 0789US10533014B2Immunoregulatory agentsFLEXUS BIOSCIENCES INC·Filed 2018·Granted Jan 14, 2020·3 cites·20 claims
- 0885US9822103B2Inhibitors of lysine methyl transferaseBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Nov 21, 2017·8 cites·7 claims
- 0983US10399933B2Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancerBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Sep 3, 2019·3 cites·13 claims
- 1082US10399932B2Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancerBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Sep 3, 2019·3 cites·13 claims
- 1182US9675571B2Inhibitors of indoleamine 2,3-dioxygenase (IDO)BRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jun 13, 2017·6 cites·11 claims
- 1278US9765018B2IDO inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Sep 19, 2017·4 cites·11 claims
- 1378US9758492B2IDO inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Sep 12, 2017·4 cites·11 claims
- 1477US10689331B2IDO inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jun 23, 2020·2 cites·17 claims
- 1577US8791257B2Substituted pyrrolotriazines as protein kinase inhibitorsMARKWALDER JAY A·Filed 2011·Granted Jul 29, 2014·6 cites·13 claims
- 1676US12145927B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Nov 19, 2024·1 cites·11 claims
- 1775US10167254B2IDO inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jan 1, 2019·1 cites·43 claims
- 1874US9895330B2IDO inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Feb 20, 2018·2 cites·10 claims
- 1965US6559152B26-substituted pyrazolo[3,4-d]pyrimidin-4-ones useful as cyclin dependent kinase inhibitorsDU PONT PHARM CO·Filed 2001·Granted May 6, 2003·3 cites·8 claims
- 2061US6531477B16-substituted pyrazolo [3,4-d] pyrimidin-4-ones useful as cyclin dependent kinase inhibitorsDU PONT PHARM CO·Filed 1999·Granted Mar 11, 2003·19 cites·9 claims
- 2156US10206893B2Immunoregulatory agentsFLEXUS BIOSCIENCES INC·Filed 2017·Granted Feb 19, 2019·0 cites·23 claims
- 2254US12391675B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2020·Granted Aug 19, 2025·0 cites·13 claims
- 2351US7659281B2HMG-CoA reductase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Feb 9, 2010·0 cites·8 claims
- 2449US12059420B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Aug 13, 2024·0 cites·6 claims
- 2545US12037344B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2019·Granted Jul 16, 2024·0 cites·34 claims
- 2639US2004248905A16-Substituted pyrazolo [3,4-d] pyrimidin-4-ones useful as cyclin dependent kinase inhibitorsFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jay A. Markwalder files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →